Embelin was previously identified as a small molecular inhibitor of the X-linked inhibitor of apoptosis proteins that can cause cell death through activating caspase-9 and subsequent cell apoptosis in prostate cancer cells with high levels of XIAP [23]. Here, CASP9 is linked to prostate cancer.